VIEMED HEALTHCARE, INC. — Form SCHEDULE 13D/A
Filed September 24, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 28/100
What the filing says
Moore Faster LLC, a Rule 144 affiliate of VieMed Healthcare (VMD), established a Rule 10b5-1 preset diversification plan with Morgan Stanley Smith Barney on September 24, 2026, to sell up to 246,000 common shares between approximately December 24, 2026 and November 30, 2027. The plan includes a commission per share (amount redacted) and is subject to Rule 144 volume limitations and VieMed's insider trading policies.
Why this rating
246,000 shares ~0.4-0.5% of typical public float; routine insider diversification plan within standard Rule 10b5-1 framework; no material transaction, restructuring, or unexpected event; administrative disclosure.
See more from September 24, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.